Get the Daily Brief
Latest Biotech News
BioNTech buys mRNA rival CureVac in $1.25 billion all-stock deal
BioNTech agreed to acquire CureVac for $1.25 billion in an all-stock transaction resolving pending patent litigation and enhancing BioNTech’s manufacturing and oncology pipeline. The deal...
Nuvation Bio gets FDA nod for Ibtrozi in ROS1 lung cancer fight
Nuvation Bio’s FDA approval of Ibtrozi, a next-generation tyrosine kinase inhibitor for ROS1-positive non-small cell lung cancer, demonstrates clinical efficacy with favorable safety, offering a...
Genentech lays off 143 workers at South San Francisco campus
Genentech announced layoffs impacting 143 employees at its South San Francisco headquarters amid operational realignment and cost optimization efforts. The workforce reduction follows previous...
BioNTech Expands Oncology Reach with CureVac Acquisition
BioNTech is acquiring CureVac in a $1.25 billion all-stock deal, resolving ongoing mRNA patent litigation and gaining CureVac’s advanced manufacturing capabilities. This strategic purchase...
FDA Clears Nuvation's Lung Cancer Drug to Challenge Industry Giants
The FDA approved Nuvation Bio’s Ibtrozi for treating ROS1-positive non-small cell lung cancer, marking the company's entry into a competitive market dominated by Pfizer, Bristol Myers Squibb, and...
Merck Enters Pediatric RSV Market with New Monoclonal Antibody
Merck received FDA approval for Enflonsia (cesrovimab), a long-acting monoclonal antibody preventing RSV lower respiratory tract disease in infants, joining existing pediatric RSV antibody...
GSK Advances Multiple Myeloma Therapy with Blenrep Data
GSK presented updated clinical trial data for Blenrep combined with Pomalyst and dexamethasone demonstrating prolonged progression-free survival in relapsed or refractory multiple myeloma...
Novel Brain-Computer Interface Enables Real-Time Speech with Natural Voice
Researchers successfully demonstrated a brain-to-voice neuroprosthesis that synthesizes speech instantaneously from neural signals in a man with ALS, capturing prosodic features such as tone and...
AI-Powered Advances Transform Cardiometabolic Drug Discovery
Deep Apple Therapeutics and Novo Nordisk entered a collaboration valued up to $812 million to develop small molecule therapies targeting non-incretin GPCRs for cardiometabolic diseases, including...
Big Data Initiatives and Biotech Expansion Drive Innovation Momentum
Basecamp Research unveiled BaseData, a 9.8-billion protein sequence database encompassing one million novel species, addressing critical data shortages hindering AI-driven biological discovery....
Synthetic Biology Boosts Antibody Production Sustainability
Enduro Genetics presented synthetic biology innovations enabling enhanced monoclonal antibody production by engineering cellular pathways to counteract micro-evolution-induced productivity loss in...
Novel Precision Antibiotic Activated by Green Light Targets Resistance
A team engineered a green-light-activatable form of penicillin, enabling spatial and temporal control of antibiotic activity to precisely target infections while reducing systemic exposure and...
Regeneron Rolls Out Proteomics Study on 200K Geisinger Samples with Olink Platform
Regeneron Genetics Center has launched a large-scale proteomics research initiative involving nearly 200,000 patient samples from Geisinger, using Thermo Fisher's Olink Explore HT platform. This...
Brain Implant Lets Man with ALS Speak and Sing with His ‘Real Voice’
A novel brain-computer interface featuring 256 implanted electrodes successfully enabled a man with severe speech paralysis from ALS to communicate expressively and modulate his voice in real...
Capricor Receives FDA Form 483 with Observations at Manufacturing Site
Capricor Therapeutics has been issued a Form 483 following an FDA inspection of its manufacturing facility, citing several observations primarily related to quality systems and documentation....
Regeneron Launches Massive Proteomics Initiative with Thermo Fisher
Regeneron Genetics Center (RGC) has initiated an extensive proteomics research project analyzing nearly 200,000 Geisinger Health System patient samples using Thermo Fisher Scientific’s Olink...
AI Accelerates Alzheimer’s Gene Research at Tempus and Northwestern
Tempus AI and Northwestern University's Abrams Research Center are collaborating to apply AI-driven data analytics to genomic data focused on Alzheimer's disease. Using Tempus’ Lens platform, the...
BioNTech Acquires CureVac to Boost mRNA Cancer Development
BioNTech has agreed to acquire CureVac in an all-stock deal valued around $1.25 billion, marking a strategic expansion of its mRNA platforms for cancer immunotherapy. The acquisition focuses...
SpliceBio Closes $135 Million Series B for Stargardt Gene Therapy
SpliceBio has secured $135 million in Series B financing to complete clinical development of SB-007, a dual AAV vector gene therapy for Stargardt’s disease, a leading inherited retinal disorder...
MaxCyte and Ori Biotech Partner to Optimize Cell Therapy Manufacturing
MaxCyte and Ori Biotech have entered a strategic collaboration to enhance manufacturing efficiency and scalability for autologous cellular therapies. The partnership combines MaxCyte’s...